Sinphar Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Sinphar Pharmaceutical Co. Ltd.
DFA Emerging Markets Small Cap Series
1,080,938
0.64%
5,000
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
1,043,507
0.62%
28,000
0%
04/30/2018
SPDR S&P Emerging Markets ETF
484,524
0.28%
0
0.02%
09/06/2018
SPDR S&P Emerging Markets Small Cap ETF
415,879
0.25%
0
0.06%
09/06/2018
DFA Emerging Markets Social Core Equity Portfolio
89,960
0.05%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
79,524
0.05%
17,000
0%
12/31/2017
John Hancock II - Emerging Markets Fund
66,177
0.04%
0
0%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
50,000
0.03%
0
0%
04/30/2018
John Hancock VIT - Emerging Markets Value Trust
42,680
0.03%
0
0%
03/31/2018
Dimensional Funds Plc - Emerging Markets Value Fund
38,348
0.02%
38,348
0%
11/30/2017
| Address |
84 Chung Shan Road
I-lan 269
Taiwan
|
|
Employees
|
- |
| Website |
http://www.sinphar.com |
| Updated |
07/08/2019 |
| Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, medicated cosmetics, nutriment and cleaning liquid. Its activities include the manufacturing and selling of healthy products and raw materials. The company's operations are carried out in Taiwan, China, Australia and North America. |
